W3 Mobile has just finished development of the Live Gooroo App, and it's good news for users with PC troubles. Users don't have to be a tech savvy "Gooroo" either. The app has a very user-friendly interface and provides helpful FAQs and support resources to assist users. It has multiple programs for diagnosing and repairing computers and includes anti-virus and anti-spyware utilities. With Live Gooroo(TM), users can save time, cut costs and fix issues themselves through an automated computer repair process. ... read more

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at BioSante Pharmaceuticals, Inc. ("BioSante" or the "Company") (Nasdaq: BPAX). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) BioSante's LibiGel product was ineffective and failed to deliver desired results; (2) the Company's LibiGel clinical demonstrations were faring poorly; and (3) LibiGel lacked any supposed multi-billion dollar market potential, ... read more

Hagens Berman Sobol Shapiro LLP today announced the launch of a new website dedicated to the firm's growing whistleblower practice. The site, which can be found at www.hb-whistleblower.com, offers resources and information for potential whistleblowers, broadly defined to include those who may bring claims under a variety of recently expanded government programs. "In an era of unbridled corporate greed, people who stand up and point out fraud play an increasingly important role in our civil society," said Steve Berman, managing partner of ... read more

Osiris Therapeutics, Inc. (NASDAQ: OSIR), today provided an update on the status of the development and commercialization agreement with Genzyme, a Sanofi company. On Wednesday, February 8, 2012, Sanofi issued a press release, which included an update on their R&D pipeline, stating that it ... read more

NetShelter Technology Media, the largest "influencer network" of technology blogs on the Web, with more than 4,500 independent bloggers reaching 150 million global readers(1), today announced that it has been chosen by AlwaysOn as one of the OnMedia 20 Companies to Watch. Inclusion in the list signifies leadership amongst its peers and game-changing approaches and technologies that are likely to disrupt existing markets and entrenched players. NetShelter was specially selected by the AlwaysOn editorial team and industry ... read more

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its President and Chief Scientific Officer, Kevin Koch, will speak at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. ... read more

Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced financial results for the year ended December 31, 2011, and offered a summary of the milestones during 2011. Financial Results Total revenues recognized for the year ended December 31, 2011, were $18,750, reflecting the amortized portion of the $500,000 licensing upfront payment from the Company's agreement with a major Korean pharmaceutical company for South ... read more

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, will release its fourth quarter 2011 financial report before the market opens on Tuesday, February 21, 2012. Anthera will host a conference call at 1 pm Eastern Time in conjunction with the release. The Company will also provide an update for both the varespladib and blisibimod clinical programs. Conference Call Access: Date: ... read more

Visa Inc. (NYSE:V) announced its participation in the following investor conferences: On Wednesday, February 15, Byron Pollitt, Chief Financial Officer, and Jim McCarthy, Global Head of Product will present at the Goldman Sachs 2012 Technology & Internet Conference in San Francisco. The discussion will begin at 4:40 p.m. Pacific Time (7:40 p.m. Eastern Time) and last for approximately 35 minutes. On Thursday, February 16, John Partridge, President, will present at the KBW Cards, Payments & Financial Technology Symposium in New York. ... read more

Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases and Hydra Biosciences, Inc., a leader in the discovery and development of novel ion channels, today announced that they ... read more

International Game Technology (NYSE: IGT) CEO Patti S. Hart announced today John Vandemore is joining the Company as Chief Financial Officer and Treasurer, effective February 13, 2012, subject to obtaining regulatory approvals. Vandemore comes to IGT from The Walt Disney Company, where he most recently served as Chief Financial Officer of Walt Disney Imagineering - the world-class creative arm of Disney's theme parks business - responsible for overseeing multi-billion dollar investments in global theme park, resort, and cruise line ... read more

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will be participating in “fireside chat” forums at two upcoming investor conferences taking place in New York. The first will take place at the BIO CEO & Investor ... read more

Every player dreams about the guitar or bass that lit the original fire to become a musician: a used Stratocaster like the one Hendrix played, or a used Les Paul like Jimmy Page's, even a used Rickenbacker, just like the one John Lennon played. They're all still out there! And you still want one, but where can you find it? Problem solved! Sam Ash Music, America's premier full-line music store chain, has launched the web's best site for used music ... read more

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it is offering to sell 6,800,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Barclays Capital Inc. is the sole book-running manager of the offering, and Halozyme intends to grant them a thirty (30) day option to purchase up to an additional 1,020,000 shares of common stock. All of the shares in the offering are to be sold by Halozyme. Halozyme intends to ... read more

BEDFORD, MA -- (Marketwire) -- 02/09/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the fourth quarter and full year ended December 31, 2011. Fourth Quarter Results Fourth quarter 2011 revenue increased 70% to $47.2 million, compared to $27.8 million in the fourth quarter of 2010. Gross profit for the fourth quarter of 2011 improved by 45% to $20.1 million, as compared to a gross ... read more

CEL-SCI Corporation (NYSE AMEX: CVM) reports financial results for the fiscal quarter ended December 31, 2011. CEL-SCI reported that net loss available to shareholders for the quarter ended December 31, 2011 was ($4,156,833) versus ($6,250,952) during the same quarter ... read more

Move, Inc. (NASDAQ: MOVE), the leader in online real estate, today announces the appointment of John Robison as chief technology officer, effective February 13, 2012. He reports directly to Move, Inc. Chief Executive Officer Steve Berkowitz, and he will be based at Move's corporate headquarters in Campbell, California. (Photo: http://photos.prnewswire.com/prnh/20120209/LA51008) As chief technology officer, Robison assumes responsibility for the Company's entire technology organization including search platform and front end engineering. He is also charged with setting Move's ... read more

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced encouraging safety and tolerability data as well as effects consistent with preclinical findings and known mechanism of action. Patients from this 4-week ... read more

Exelixis, Inc. (Nasdaq:EXEL) today announced that it plans to offer, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of ... read more

SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/09/12 -- Theravance, Inc. (NASDAQ: THRX) reported today its financial results for the fourth quarter and full year ended December 31, 2011. Revenue for the full year was $24.5 million. Net loss for the fourth quarter and full year of 2011 was $37.0 million and $115.3 million, respectively, compared with $19.3 million and $83.9 million for the same periods of 2010. Net loss per share was $0.45 and $1.41 for the ... read more